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In pediatric environmental health research,
information about family members is often
directly sought or indirectly obtained in the
process of identifying child risk factors and help-
ing to tease apart and identify interactions
between genetic and environmental factors. For
example, research on neurodevelopmental disor-
ders such as autism or other developmental dis-
abilities may benefit from biological or
psychological testing of healthy siblings, the col-
lection of health or occupational information
from parents, the sampling of home items for
toxicants, or observation of family social interac-
tions. A common model of survey and epidemi-
ologic research is to ask the primary participant
(e.g., the child or adolescent) for information
about the home environment that may elicit
personal data about family members. For exam-
ple, a study of pesticide exposure may ask chil-
dren or adolescents about parental occupation
and hygiene habits (e.g., does the parent wear
his/her work shoes into the house?). Research
on the effects of secondary smoke on children’s
respiratory health may include questions
directed to the child regarding parent or sibling
smoking behaviors and health history (asthma,
lung cancer, emphysema). Although parents
may have given permission for their child to be
involved in the research, they may not be aware
of the extent of the questions asked.
Increasingly, research involving children
uses longitudinal designs to identify the devel-
opmental trajectories of environmental health
problems and the single or joint health effects
of heredity and prenatal and postnatal exposure
to environmental agents. By its nature, such
research often involves asymptomatic children
who will or will not be affected by environmen-
tal agents under investigation or who will
develop a disorder previously not known to be
associated with an environmental agent. For
example, the functional expression of prenatal
or postnatal exposure to environmental neuro-
toxins on brain development may not appear
until late childhood or early adolescence or may
appear in different forms throughout the life
span (Weiss 2001).
Further, a disease suspected to be a product
of gene–environment interactions may occur
more frequently in certain population groups,
and these groups may be disproportionately
exposed to stigmatization when research results
are disseminated. For example, research ﬁnd-
ings suggesting that passive tobacco smoke
increases complications in pediatric sickle cell
patients have recently been reported in the
media. Because this disease disproportionately
affects African Americans, epidemiologic stud-
ies asking children about their parents’ smoking
behaviors may unfairly place this population at
greater risk of stigmatization regarding respon-
sible parenting (West et al. 2003). 
The direct and indirect implications of pri-
vacy violations on the health and social welfare
of families and communities places the ade-
quacy of privacy protections at the forefront of
ethical concern in the design, implementation,
and dissemination of research on children’s
environmental diseases [National Research
Council (NRC) 2005]. In this article I explore
issues and potential solutions for the privacy
and informed consent challenges of pediatric
environmental health research to adequately
protect the rights and welfare of family mem-
bers and communities.
Are Family Members Research
Participants?
Institutional review boards (IRBs) reviewing
studies in which children describe family
behaviors may not consider parents or siblings
research participants and therefore fail to con-
sider potential privacy risks to family members
in the risk–beneﬁt analysis (Mathews 2000).
Federal regulations governing protection of
human subjects in research deﬁne a “human
subject” as a living individual about whom
an investigator obtains data through inter-
vention or interaction with the individual or
about whom the investigator has recorded
individually identiﬁable private information.
Individuals who are not considered human
subjects under this definition are thus not
offered protections under current federal regu-
lations (Botkin 2001). When secondary par-
ticipants are not considered human subjects,
ethical procedures for obtaining informed
consent and protecting conﬁdential informa-
tion may be neither required nor considered.
Identiﬁable data. When there is no direct
intervention or interaction with an individual,
in order for a person to be considered a
“human subject” under federal regulations, the
individual’s identity must be readily ascertained
by the investigator or associated with the infor-
mation [Department of Health and Human
Services (DHHS) 2005, 45 CFR 46.102(f)]. As
Botkin (2001) has pointed out, whether a fam-
ily member is protected under federal regula-
tions for human subjects research thus depends
on whether the data include unique individual
identiﬁers (e.g., name, address, social security
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member’s identity can be easily ascertained
(e.g., the child’s unique identiﬁers or data on
individual characteristics such as sex, age, eth-
nicity, and education in combination with a
rare environmental health problem investigated
at an identiﬁed data collection site). 
Family privacy concerns may not be an
issue when data collected at a single point in
time from a large geographically dispersed sam-
ple are anonymized and reported in the aggre-
gate. By contrast, family privacy concerns may
be raised a) when anonymous data are col-
lected from a small sample of individuals with
a rare environmental health risk in a small geo-
graphic area or identiﬁed health care or school
setting, or b) when longitudinal investigations
require that unique identifiers and contact
information is linked to subject codes, and the
primary participant shares the same address
and surname as other family members.
Genetic family privacy. Data collected on a
child’s genetic code provides probabilistic
health information about the child’s parents
and siblings. Recognizing the risk to both the
child and close relatives if private genetic infor-
mation is disclosed, Annas et al. (1995) pro-
posed that protections for individual genetic
privacy must encompass not only the collection
and storage of DNA samples (typically in the
form of blood samples), but the information
obtained from analyzing DNA samples and dis-
tribution of such samples to other investigators. 
Under Annas et al.’s proposed Privacy Act
of 1995, private genetic information includes
any information about an identifiable individual
that has been obtained (1) from an analysis of the
individual’s DNA; (2) from an analysis of the
DNA of a person to whom the individual is geneti-
cally related; (3) from knowing the status of the
individual in a pedigree or family history that has
been developed or analyzed for a particular heredi-
tary condition; and that (4) conﬁrms the diagnosis
of a disease; (5) determines the presence of a gene
or genes, or a speciﬁc gene marker or gene markers;
(6) indicates that the individual is at increased or
decreased risk of developing a disease as a result of
having inherited a gene; or (7) establishes that the
individual is a carrier of a gene. (Annas et al. 1995)
To protect the privacy rights of family mem-
bers, Annas et al. (1995) recommend that indi-
viduals who will be involved in pedigree or
genetic linkage analysis be counseled on the pri-
vacy implications of this research, including the
fact that other family members may ﬁnd out
private genetic information about them and
that during the course of the study it may be
determined that some family members are not
in fact genetic relatives. At the same time, indi-
viduals should have access to individual records
if such access does not violate the privacy rights
of other family members (Annas et al. 1995).
The proposed act has not been formally
adopted; and although the Health Insurance
Portability and Accountability Act (HIPAA)
(2002) has increased protection of identiﬁable
genetic information that is used for the assess-
ment or treatment of an individual, it does not
directly apply to privacy of genetic information
obtained solely for the purpose of research.
Privacy and harm. Classifying family mem-
bers as research participants affords them cer-
tain protections under federal rules. Two of
these protections are informed consent and
evaluation of potential benefits and risks of
research participation. If information regarding
family members is considered identiﬁable and
private, investigators may consider whether to
request from their IRB a waiver of informed
consent from family members. Federal regula-
tions permit IRBs to grant a waiver of informed
consent for research if it presents no more than
minimal risk, the waiver would not adversely
affect participants’ rights or welfare, the research
could not be practicably carried out without
the waiver, and, whenever appropriate, the
participants are provided with additional per-
tinent information [DHHS 2005, 45 CFR
46.117(d)]. In requesting consent waivers for
family members, investigators must be able to
demonstrate to IRBs that the probability and
magnitude of privacy harms that would rea-
sonably be expected does not rise above mini-
mal risk defined as “the probability and
magnitude of harm or discomfort anticipated
in the research are not greater in and of them-
selves than those ordinarily encountered in
daily life or during the performance of routine
physical or psychological examinations or tests”
[DHHS 2005, 45 CFR 46.102(i)]. 
Magnitude and probability of harm. One
element of the minimal risk criteria requires a
decision regarding whether and to what degree
research procedures may harm participants.
Harm may be incurred by release of private
information obtained through primary partici-
pant reports about parenting behaviors or
health behaviors, or biological markers obtained
from the primary participant, not otherwise
available to physicians, health insurers, school
ofﬁcials, child welfare services, the courts, or
other family members. Such harms can include
social stigma, school or employment discrimi-
nation, criminal charges, or limits on health
coverage. The magnitude of harm of disclosure
of data collected during environmental health
investigations will depend on the type of infor-
mation collected. Will biological markers reveal
a previously undetected probability of a genetic
health disorder or presence of an environmental
toxicant that will jeopardize health or home
insurance? Might disclosure of children’s survey
responses regarding the presence of legal or ille-
gal toxicants in the home prompt a child
neglect or criminal investigation? 
The extent to which the magnitude of
potential harm will curtail waiver of family
member consent depends on the “probability”
of harm. The probability that data collection
will lead to harm depends on the type of
information collected and whether sound poli-
cies for protecting confidentiality have been
put into place. For example, Knoppers (2000)
argues that in most instances stored genetic
information does not provide sufﬁcient infor-
mation about disorders resulting from multiple
allele–environment interactions to cause pri-
vacy harms. The probability of harm can also
be minimized through conﬁdentiality proce-
dures. For example, investigators can obtain a
Public Health Service (PHS) Certificate of
Confidentiality to protect research records
from subpoena for criminal investigations
regarding family use of illicit substances. The
certificate will not, however, protect against
court-ordered requests for information regard-
ing child abuse or neglect (Fisher et al. 1996). 
Some assume that the use of children’s
reports of parental behaviors will not meet
legal or health care standards that could
endanger participants. Botkin (2001) presents
a cogent argument against this position, not-
ing that because all science rests on the validity
of data collected, investigators designing a
study must provide ample evidence of the
validity of second-hand reports if they are rely-
ing on such reports as a means of collecting
data about familial variables interacting with
environmental factors.
The ordinarily encountered standard.
Whether the degree of probability and magni-
tude of harm merits consideration of a consent
waiver depends on whether the harms are those
usually encountered in daily life or during rou-
tine physical or psychological examinations. To
evaluate the privacy risks under this criterion,
investigators must determine whether the
behavioral reports or biological tests used in the
research reveal information that practitioners
normally acquire during routine visits or that
school staff acquire during routine child testing
or parent interviews. For example, physicians
routinely ask about patient smoking behaviors,
but do not routinely test for the presence of
certain toxicants in the blood stream. Schools
may routinely conduct tests of reading skills,
and parent–teacher interviews may routinely
include questions about aspects of the home
environment that may or may not be con-
ducive to homework or school performance,
but do not ordinarily include questions about
the presence of toxic agents in the home. In
addition, private information that is collected
under routine medical or school procedures
may enjoy greater federal protections against
disclosure under HIPAA (2002, 45 CFR Part
160 and Subparts A & E of Part 164) and the
Family Educational Rights and Privacy Act
(1974, 20 U.S.C. 1232-34 CFR Part 99). 
Protecting family privacy rights. In design-
ing protections for human participants, investi-
gators must determine whether the collection
of personal information about family members
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privacy that require family members them-
selves to be considered research participants
(Botkin 2001; NRC 2005). If it is determined
that privacy concerns necessitate designation of
family members as human participants, then
investigators need to either address these issues
in the human subjects protection procedures
submitted to their IRBs (e.g., informed con-
sent; minimizing risks of disclosure of conﬁ-
dential information) or modify data collection
procedures to ensure privacy protections. 
Longitudinal Studies and
Databases
Longitudinal designs involve multiple data
collection periods sometimes initiated as early
as the prenatal period and continued through
adolescence or adulthood. The type of per-
sonal information collected and data collec-
tion methods typically change as the child
matures. For example, biological markers may
be acquired through umbilical cord blood at
birth and by saliva samples, blood or MRIs
during childhood and adolescence. Behavioral
information may be collected from parental
reports during the preschool and early school
years and through self-reports during late
childhood and early adolescence.
Anonymizing longitudinal data. Use of
previously collected data following participant
withdrawal does not present the same ethical
challenges when cross-sectional designs are
used, because such designs permit anonymiz-
ing of data. By contrast, longitudinal designs
must establish some way of identifying partic-
ipants to link information obtained at differ-
ent data collection points. Investigators can
deidentify information for use by other inves-
tigators during or after the collection of data
without risking the privacy rights of partici-
pants in most cases. 
The ongoing nature of consent to longitu-
dinal studies. Given the lapses between data
collection periods, the changing nature of data
collection, and children’s developing ability to
understand their right to privacy and conﬁden-
tiality, the privacy rights of child participants
in longitudinal studies are best protected by
viewing parental permission and child assent as
ongoing educational processes that are moni-
tored and repeated at appropriate periods
(Fisher et al. 1996). Reassent and parental per-
mission procedures conducted at appropriate
data collection intervals gives children and par-
ents an opportunity to reevaluate the privacy
risks of continued participation in light of the
child’s increasing maturity, social experience,
and evolving social, political, and economic cli-
mates. In addition, informed consent must be
newly obtained for children who during the
course of the study reach the legal age for con-
sent, although under some circumstances IRBs
may waive the consent requirement (DHHS
2006). The possibility that some families may
drop out of the research when given this
opportunity should be factored into initial esti-
mations of sample sizes required for sufﬁcient
power. 
The right to withdraw data. The storage of
biological and behavioral materials in data
banks raises difficult consent challenges in
almost all health research settings, but especially
in environmental health research involving chil-
dren. First, as noted by Chen et al. (2003),
there is little scientiﬁc or public consensus on
whether individuals ought to be permitted to
withdraw previously collected research samples
if they exert their right to withdraw from the
study. This issue becomes especially challenging
when children whose parents had given permis-
sion for the child’s materials to be banked
reaches the legal age of consent and wish their
data to be withdrawn. HIPAA regulations rele-
vant to the use of previously collected protected
health information (PHI) for research purposes
may set a precedent for such consensus. HIPAA
explicitly provides an exception to the right of
research participants to revoke their authoriza-
tion for the future use of such information, but
it is less clear on the use of the samples them-
selves for future research. If the PHI has already
been obtained and used on the basis of the orig-
inal authorization, the investigator may main-
tain data analysis based on the information,
although no additional information may be
used or disclosed following revocation [DHHS
2005, 45 CFR 164.508(b)(3)(i); Fisher 2003a].
With the advances in technologies for analysis
and characterization of genetic information
from stored samples, this issue may become
even more challenging.
Ethical distinctions between guardian per-
mission and child assent. At minimum, initial
guardian permission and repermission proce-
dures should include a description of the inves-
tigators’ plans for future use of already collected
data in the event of participant withdrawal.
This provides an opportunity for guardians
who have concerns regarding future use to
refuse to permit their child to participate at the
onset of a longitudinal study or to dissent to
continued participation as data collection pro-
cedures change over time.
Informing guardians about planned uses
for stored data on participant withdrawal does
not resolve privacy concerns for the children
involved. First, in studies initiated prenatally or
at birth, the child has no role in the participa-
tion decision. Children and young adolescents
informed during reconsent procedures about
plans for future use of collected data have nei-
ther the mature cognitive skills nor the experi-
ence to understand the privacy implications of
such policies. In appreciation of the unique
nature of children’s research, it may be ethically
appropriate to permit the withdrawal of data
held in data banks at the participant’s request.
This policy need not extend indefinitely.
Rather, the right of participants to withdraw
their data might be extended only until they
reach the age of majority or until the study has
been completed and data anonymized. Again,
investigators should take into account the possi-
bility of such data withdrawals in their power
estimates (Chen et al. 2003).
Small-Area, Unique, and Hard-
to-Reach Populations
Individuals living in small, unique areas where
exposure to environmental toxicants are
hypothesized to be related to high proportions
of childhood disorders run greater risks of per-
sonal identification than participants from
larger samples. For example, participants or
their families may be personally identiﬁed when
demographic information permits detailed
cross-tabulation of small numbers of partici-
pants (Taylor 2001). The identiﬁcation of indi-
vidual health service providers may be similarly
vulnerable. Do principles of justice require that
environmental researchers accept responsibility
for the effect of knowledge dissemination on
small or unique populations?
Wing (2002) describes a poignant situation
in which members of a small community par-
ticipated in research designed to uncover
whether noxious odors coming from a local hog
production plant were indicative of dangerous
levels of toxicants. The investigators made every
effort to protect community conﬁdentiality by
removing demographic information on census
block groups used to match communities and
exact information about the size of the hog
operations. Nonetheless, because the investiga-
tors were associated with a public university,
the pork industry succeeded in obtaining a
court order for all documentation from notes,
work papers, and participant payments. As a
result, community members were threatened by
the hog industry employers, and some lost their
jobs when they agreed to provide to researchers
clinical data to test whether such health con-
cerns were legitimate. One important lesson
from this incident is that investigators should
not promise conﬁdentiality without knowing in
full what they can keep conﬁdential. 
The need for small population privacy
protections. When working with rural or small
and unique ethnic populations, investigators
need to be aware of the added difficulties of
protecting the confidentiality of individuals
and their communities. When health data col-
lection is conducted in institutional settings,
investigators need to take steps to protect par-
ticipant privacy, recognizing that institutional
staff may have different disclosure and report-
ing obligations or may use the knowledge in
ways that participants and their guardians may
ﬁnd undesirable (Fisher et al. 2002). 
Conventional confidentiality procedures
may not be sufﬁcient to protect the privacy of
Fisher
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individuals in small, rural, or closely knit ethnic
neighborhoods. For example, in such settings,
recruitment efforts, if they involve door-to-door
sampling or walk-ins to an easily identiﬁable
research recruitment location, can alert com-
munity members to the nature of a child’s
actual or suspected disorder. Similarly, media
reports of research describing the unique char-
acteristics of unnamed, but small or unique
ethnic communities or tribes may lead to pub-
lic identification and stigma (Mohatt and
Thomas 2006; Noe et al. 2006; Norton and
Manson 1996; NRC 2005). Finally, proce-
dures for protecting confidentiality may be
seriously challenged in epidemiologic or ethno-
graphic studies of small communities, when
interviewers drawn from the community have
other role relationships with the participant
families (Fisher et al. 2002). 
Justice and research burdens. Federal
guidelines are designed to protect individuals
but not populations or communities from risk
(American Academy of Pediatrics 2004).
Principles of social justice make it critical for
investigators to consider whether families from
lower socioeconomic statuses are unfairly bur-
dened with the conﬁdentiality risks associated
with environmental research. Poor families are
more likely to live near toxic facilities or waste
sites or be exposed to residential or occupa-
tional environmental inequities such as lead
poisoning, air pollution, food contaminants,
and industrial toxicants (Lambert et al. 2003).
Although individuals with higher incomes are
also exposed to these environmental hazards,
from a practical perspective it may be easier to
identify research populations in communities
in which risk is concentrated. Environmental
researchers must thus consider whether poorer
populations are unjustly asked to bear the bur-
den of privacy risks for the benefit of large-
scale public health. 
Deﬁning community. Participatory research
is a promising approach to addressing potential
injustices of including small or disenfranchised
populations in research. A community can refer
to individuals from a common ethnic group
who share culture, traditions, language, and reli-
gion or to persons from different ethnic groups
who share similar barriers to employment, edu-
cation, housing, or quality health care rooted in
exposure to historical discrimination and con-
temporary racial and ethnic biases (Fisher et al.
2002). Identifying persons who can best repre-
sent research-relevant concerns of prospective
participants requires an understanding of the
social structures and relationships that deﬁne a
community (Weijer and Emanuel 2000). 
The particular protections that commu-
nity consultation provides will vary with the
extent of community cohesion and whether
there are individuals with legitimate authority
and understanding who can reﬂect the views
and interests of prospective participants. For
example, families living on American Indian
and Alaska Native land may agree with the
tradition of empowering tribal councils with
authority to make binding decisions about
research participation of tribal members
(Norton and Manson 1996). In contrast, chil-
dren and families drawn from diverse Spanish-
speaking or Asian-American groups may have
different countries of family origin, immigra-
tion histories, ethnic identiﬁcations, and levels
of acculturation, making it more difﬁcult for
investigators to identify appropriate cultural
representatives (Fisher et al. 2002). There can
also be instances where interests of the larger
community are not congruent with the best
interests of vulnerable children and families
within the community (Macklin 1999).
Parents of children with susceptibility to envi-
ronmental health disorders may favor an envi-
ronmental intervention in the hopes that it
will prevent the onset of an environmental dis-
ease, whereas nonaffected members of the
community may reject the trial out of concern
about group stigma (Fisher et al. 2002). 
Conclusions
Children’s privacy rights need not be conceptu-
alized as isolated or isolating (Walker 2002).
Children’s involvement in environmental health
research does not occur in a vacuum, but within
the context of federal, institutional, and family
protections (Fisher and Masty 2006; Kodish
2003). First, investigators with their IRBs deter-
mine whether the balance of research risks and
prospective beneﬁts are ethically justiﬁed for the
population to be recruited. Second, parents
decide whether the risk–benefit balance is
appropriate for their own child’s unique charac-
teristics and experiences. If parents give permis-
sion for research participation, developmentally
ﬁtted child assent procedures allow children to
decide whether they wish to participate in the
research procedures and purposes, as they
understand them (Fisher 2003b). Creating
opportunities for continued research education
and periodic consent conferences can create
research contexts that minimize family stress,
optimize children’s input into the participation
decision, and ensure that privacy needs are met.
Family-focused and developmentally ﬁtted pro-
cedures that protect family member privacy
while promoting child participants’ maturing
autonomy are thus essential to an informed
consent ethic of respect and care.
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